Effects of Angiotensin II Receptor Blockers on Relationships Between 24-Hour Blood Pressure, Autonomic Function, and Health-Related QOL

References

• Dahlöf B, Lindholm LH, Carney S, Pentikäinen PJ, Östergren J. Main results of the losartan versusamlodipine (LOA) study on drug tolerability and psychological general well-being. J Hypertens. 1997; 15: 1327–1335
   PubMed Web of Science ®Google Scholar
• Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J. Efficacy, tolerability and effects on quality of life of losartan, alone or with hydrochlothiazide versus amlodipine inpatients with essential hypertension. Clin Therapeutics 1996; 18: 608–625
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Kawashima T, Kunitake T, Koide S, Fujimoto H. Symptom assessment and quality of life in hypertensive patients following modification of antihypertensive therapy to a regimen containing valsartan. J Clin Outcome Res. 2004; 8: 1–14
   Google Scholar
• Thaker D, Frech F, Gil M. Adverse event reporting of ACEI and ARB associated angioedema. Am J Hypertens. 2005; 18: A116
   PubMed Web of Science ®Google Scholar
• Mancia G, Zanchetti A, Agebiti-Rosei E, Benemio G, Cesaris RD, Fogari R, Pessino A, Porcellati C, Salvetti A, Trimarco B. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997; 95: 1464–1470
   PubMed Web of Science ®Google Scholar
• Fagard RH, Staessen JA, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens. 1997; 15(part 1)1493–1502
   PubMedGoogle Scholar
• Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998; 98: 1892–1897
   PubMed Web of Science ®Google Scholar
• Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multi-biomedical recorder. Hypertension 1996; 27: 1318–1324
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Mark AL, Abbound FM. Sympathetic nerve activity during sleep in normal subjects. N Engl J Med. 1993; 328: 303–307
   PubMed Web of Science ®Google Scholar
• Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcome study: an application of methods for monitoring the results of medical care. JAMA 1989; 262: 925–930
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinki M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Health Institute, Boston, MA 1994
   Google Scholar
• Okano Y, Tochikubo O, Umemura S. Relationship between base blood pressure during sleep and health-related quality of life in healthy adults. J Hum Hypertens. 2007; 21: 135–140
   PubMed Web of Science ®Google Scholar
• World Health Organization. Arterial hypertension: Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1978; 628: 7–56
   PubMedGoogle Scholar
• Clark S, Fowler S, Coats A, Radaelli A, van der Putt M, Bird R, Conway J. Ambulatory blood pressure monitoring: Validation of the accuracy and reliability of the TM2420 according to the AAMI recommendations. J Hum Hypertens. 1991; 5: 77–82
   PubMed Web of Science ®Google Scholar
• Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985; 248: H151–H153
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998; 11: 1037–1044
   Google Scholar
• Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol. 1998; 11: 1045–1053
   Google Scholar
• Furberg C, Psaty B. Corrections to the nifedipine metaanalysis. Circulation 1996; 93: 1475–1476
   PubMedGoogle Scholar
• Furberg C, Psaty B, Meyer J. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326–1331
   PubMed Web of Science ®Google Scholar
• Baumgart P, Walger P, Fuchs G, Dorst KG, Vetter H, Rahn KH. Twenty-four hour blood pressure is not dependent on endogenous circadian rhythm. J Hypertens 1989; 7: 331–334
   PubMed Web of Science ®Google Scholar
• Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and Nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens. 2004; 17: 1050–1055
   PubMed Web of Science ®Google Scholar
• Kakinoki S, Nomura A, Takechi S, Kitabatake A. Effects of short-and long-acting calcium channel blockers on the relationship between blood pressure and physical activity. Am J Hypertens. 2001; 14: 66–69
   PubMed Web of Science ®Google Scholar
• Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002; 15: 321–325
   PubMed Web of Science ®Google Scholar
• Wolk R, Kulakowski P, Ceremuzynski L. Nifedipine and captopril exert divergent effects on heart rate variability in patients with acute episodes of hypertension. J Hum Hypertens. 1996; 10: 327–332
   PubMed Web of Science ®Google Scholar
• Klein I, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and Losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol. 2003; 14: 425–430
   PubMed Web of Science ®Google Scholar
• Schwartz GL, Bailey KR, Mosley T, Knopman DS, Jack CR, Canzanello V, Turner ST. Association of ambulatory blood pressure with ischemic brain injury. Hypertension 2007; 49: 1228–1234
   PubMed Web of Science ®Google Scholar
• Julius S, Nesbitt S. Sympathetic overactivity in hypertension: a moving target. Am J Hypertens. 1996; 9: 113s–120s
   PubMed Web of Science ®Google Scholar
• Sakata K, Kumagai H, Osaka M, Onami T, Matsuura T, Imai M, Saruta T. Potentiated sympathetic nervous and rennin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Circulation 2002; 106: 620–625
   PubMed Web of Science ®Google Scholar
• Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol. 2006; 290: H1706–1712
   PubMed Web of Science ®Google Scholar
• See S, Stirling AL. Candesartan cilexetil: an angiotensin II-recepter blocker. Am J Health Syst Pharm. 2000; 57: 739–746
   PubMed Web of Science ®Google Scholar